Group 1 - Zhongheng Group's stock increased by 5.05%, reaching 2.91 CNY per share, with a trading volume of 158 million CNY and a turnover rate of 1.76%, resulting in a total market capitalization of 9.298 billion CNY [1] - The company, established on July 28, 1993, and listed on November 30, 2000, is based in Wuzhou, Guangxi, and its main business involves investments and management in pharmaceuticals, energy, infrastructure, urban public utilities, hotel tourism, logistics, and real estate development [1] - The revenue composition of Zhongheng Group includes 66.19% from pharmaceutical sales, 19.21% from food sales, 5.58% from daily chemical products, 5.17% from other products or services, 2.47% from real estate sales, and 1.38% from other sources [1] Group 2 - Among the top ten circulating shareholders of Zhongheng Group, a fund under GF Fund Management ranks as a significant shareholder, with the GF CSI 1000 ETF (560010) newly entering the top ten in the third quarter, holding 11.1405 million shares, which is 0.35% of the circulating shares [2] - The GF CSI 1000 ETF, established on July 28, 2022, has a current scale of 35.303 billion CNY, with a year-to-date return of 23.39%, ranking 2030 out of 4197 in its category, and an annual return of 18.66%, ranking 2450 out of 4147 [2]
中恒集团股价涨5.05%,广发基金旗下1只基金位居十大流通股东,持有1114.05万股浮盈赚取155.97万元